The M/29® provides a new, cost‐effective standard in comfort, safety and productivity designed specifically for the midterm category. The M/29® is an ideal solution for those patients requiring most common peripheral IV therapies. The M/29® system is a product platform serving multiple segments and a nearly perfect response to the pending CDC Guidelines for The Prevention of Intravascular Device‐Related Infections which recommends that clinicians “Use a midline catheter or peripherally inserted central catheter (PICC), instead of a short peripheral catheter, when the duration of IV therapy will likely exceed six days.”

  • Peripheral IV – existing policy applies
  • Simple to place with minimal training
  • Over the needle insertion – minimal draping required
  • Eliminates risk of airborne or touch contamination
  • Indwelling time up to 4 weeks
  • Applicable to all standard PIV and Midline uses
  • Peelguard® eliminates catheter migration
  • Cost effective for therapies in excess of 4 days
  • Eliminates the need for frequent replacement of PIV, reduces needle sticks – preserves vascularity

Our Target Markets:

  • Acute Care Settings
  • Sub Acute Care Settings
  • Long Term Care Settings
  • Home Care
  • Emergency Medicine

The M/29® catheter system. Bridging the Midterm Gap

The Challenge: Healthcare systems are facing intense pressures to reduce costs and increase productivity as population’s age, nursing resources dwindle, and reimbursement policies change.

Aging populations are driving an increase in vascular access procedures and the need to preserve the vascular system. Hospitals are no longer reimbursed for hospital acquired infections and midterm vascular access device choices have been limited.

The M/29® to the Rescue: The M/29® offers the caregiver a superior choice to short peripheral catheters, traditional midline catheters, and PICC’s for the most common intermediate dwell applications – the simplicity of short peripheral insertion, all the care delivery benefits of a midline, soon to be power injectable and breakthrough infection management – the right line from the start

A Growing Crisis in Infusion Therapy

A Growing Crisis in Infusion Therapy

Comparison of Peripheral Catheters

Comparison of Peripheral Catheters

M/29® to the Rescue - Captures benefits of short PIV and PICC

Shorting coming of current options M29 Solution

In Dwelling Term > 6 Days

  • Multiple Short PIV’s
  • Inappropriately applied PICC
  • Single bedside placement – indwelling for up to 29 days

In Dwelling Term > 6 Days

  • Multiple Short PIV’s
  • Inappropriately applied PICC
  • Single bedside placement – indwelling for up to 29 days


  • 6.54 sticks per patients on average
  • Costly PICC Placement Procedure
  • Reduced to a single stick on average

Patient / caregiver safety

  • Direct correlation between needle sticks, bloodstream infection and hospital acquired infections
  • Deterioration of vasculature associated with multiple sticks
  • Increased risk of mechanical phlebitis/thrombosis
  • Minimizes needlesticks
  • Preserves integrity of vasculature
  • Flexible catheter lowers risk of mechanical phlebitis/thrombosis
  • Increased hemodilution minimizes risk of chemical phlebitis

Patient satisfaction

  • IV restarts – a frequent complaint on patient satisfaction surveys
  • Reduced sticks increases patient satisfaction

Lower hospital cost (labor/disposables)

  • Up to 5 catheter placements per treatment for short PIV
  • Specialist required for PICC
  • Can be inserted in less than 10 minutes
  • Only 1 catheter needed per treatment cycle
  • No specialist required

Home setting

  • IV restarts not available at home
  • Reliable access in a care setting where IV restarts not available